OpenVSafe by OpenVAERS
Search V-safe

YSU-18317-95729

1 vaccination 0 coded responses 5 check-ins 0 free-text entries 2 call cases
Sex
Female
Age at first dose
21-25
ZIP prefix
801 / CO
Registered
2021-03-24
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-23
    Dose 1 — Janssen/Johnson & Johnson
  2. 2021-03-24
    Registered in v-safe
  3. 2021-03-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  4. 2021-03-24
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  5. 2021-03-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  6. 2021-03-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Nausea
    Adult check-in
  7. 2021-03-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  8. 2021-03-27
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  9. 2021-03-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Nausea
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-23Janssen/Johnson & Johnson

Call center

ReportedOutcomeVAERS-related outcome
2021-03-24 priority 2/3
2021-03-27 priority 2/3

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

No MedDRA codes.